Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	75.45	-475.54	-1936.96
Graham Fair Price	43.17	8.86	6.19
PEG	-40.37	< 0.005	< 0.005
Price/Book	-4.09	-0.04	-0.04
Price/Cash Flow	47.47	-13.16	-25.06
Prices/Earnings	-47.96	0.43	0.83
Price/Sales	-47.96	0.20	0.39
Price/FCF	47.47	-13.16	-25.06
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.01	0.01
Operating Margin	-81.81	-0.02	0.13
ROA	100.00	0.02	< 0.005
ROE	-0.01	-0.02	-100.00
ROIC	0.01	< 0.005	-60.32
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.04	0.05	-4.76
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	10.11	-1.36	-86.51
EPS QOQ	1.15	1.00	-12.73
FCF QOQ	-0.87	-0.98	-13.01
Revenue QOQ	-0.66	1.00	52.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.03	0.01	-50.00
Days Sales Outstanding (DSO)	2.15	1.78	-17.40
Inventory Turnover	3499.17	6998.34	100.00
Debt/Capitalization	1.87	1.95	4.21
Quick Ratio	< 0.005	< 0.005	42.30
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	-12.16	-12.32	-1.24
Cash	0.02	0.02	1.24
Capex	-0.02	-0.05	-102.47
Free Cash Flow	-0.02	-0.04	-100.62
Revenue	1.20	2.44	102.47
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	< 0.005	< 0.005	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1903.12	-466.51	75.49
Naive Interpretation	Member

06 - Financial Health · Bad

Rating